We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomarkers for Stress Levels Measured on Automatic Platform

By LabMedica International staff writers
Posted on 21 Jun 2010
Two substances in the saliva can be indicative of stress levels in people under pressure. More...


Salivary immunoglobulin (IgA) and cortisol, levels can be measured in an automatic liquid handling system based on enzyme immunoassays. Cortisol is a corticosteroid hormone and IgA is an antibody that plays a critical role in mucosal immunity. The levels of these two biomarkers can be correlated with the degrees of stress a person is suffering.

Enzyme-linked immunosorbent assays for IgA and cortical, the "stress” hormone, are being performed using the Tecan automated liquid handling platform (Tecan Switzerland AG; Männedorf, Switzerland). Psychologists have been using the system to explore stress levels and the immune system at Anglia Ruskin University (Cambridge, UK).

One recent project looked at caregivers of people with dementia, and it was discovered that the long-term chronic stress they experience tends to raise levels of IgA. At the other extreme, a number of volunteers were followed through their first tandem parachute jump, looking at progressive increases in salivary cortisol before the event, and the effect this has on the immune system's reaction.

The Tecan platform to automate ELISAs considerably increases daily throughput from a maximum of 100 samples manually, to over 600 on the Tecan system. The system has a positive identification scanner for barcode recognition, and it is linked to software for tracking, database integration and printing, offering full automation of the whole process.

The scalable Tecan Freedom EV liquid handling workstations are capable of handling a variety of automated microplate tests including ELISAs, enzyme immunoassays (EIAs), radio immunoassays (RIA) without detection, fluorescence immunoassays (FIA), and heterogeneous and homogenous assay types; any assay requiring incubation, washing and reading steps. Modules can be seamlessly integrated onto the workstations and controlled by Freedom EVOwarePlus dynamic scheduling software enabling hands-free automation, from distribution of the sample to detection of the assay signal.

Related Links:

Tecan Switzerland AG
Anglia Ruskin University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.